The impact of hybridization sequencing on the field of DNA sequence analysis, in general, and on the Human Genome Project, in particular, will be substantial. Once fully implemented, hybridization sequencing will result in a reduction in the cost-per-base by at least an order of magnitude compared with currently employed methods. Much of that savings will be realized through the elimination of materials and labor required for DNA sequencing using conventional gel-based approaches. In addition, further gains in throughput will be realized from the elimination of a number of limitations imposed by gel-based sequencing methods. As it is currently being developed, hybridization sequencing is flawed in several respects. First, it requires the synthesis of at least 65,536 interrogation probes, limiting the practical application of the technology to high-cost "DNA chip"-based products. Second, due to the size of DNA fragments targeted for interrogation, control over what is known as the "branching" problem is seriously impaired. This impairment gives rise to unacceptably high probabilities of failure. We will use an alternative approach in which a total of only 2048 probes are required to interrogate kilobase-size fragments with a very high probability of success. The method is compatible with both "DNA chip" and hybridization membrane technologies. Once developed, the hybridization sequencing product will be extremely cost-effective and immediately applicable to even small, modestly-equipped laboratories.Awardee's statement of the potential commercial applications of the research: The commercial potential of the research is substantial and comprises two avenues for development. The first is an inexpensive membrane-base product broadly applicable to small and medium-scale projects, could be developed and commercialized within three years. In addition, the method described herein provides the means by which an effective "DNA chip"-based instrument could be developed and marketed at a cost affordable by most laboratoriesNational Cancer Institute (NCI)
